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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is an age-dependent neurodegenerative disease
that causes motor neuron degeneration, paralysis and death. Mutations in Cu, Zn superoxide
dismutase (SOD1) are one cause for the familial form of this disease. Transgenic mice expressing
mutant SOD1 develop age-dependent motor neuron degeneration, skeletal muscle weakness,
paralysis and death similar to humans. The mechanism whereby mutant SOD1 induces motor
neuron degeneration is not understood but widespread mitochondrial vacuolation has been
observed during early phases of motor neuron degeneration. How this vacuolation develops is not
clear, but could involve autophagic vacuolation, mitochondrial permeability transition (MPT) or
uncharacterized mechanisms. To determine which of these possibilities are true, we examined the
vacuolar patterns in detail in transgenic mice expressing mutant SOD1G93A.
Results: Vacuolar patterns revealed by electron microscopy (EM) suggest that vacuoles originate
from the expansion of the mitochondrial intermembrane space and extension of the outer
mitochondrial membrane. Immunofluorescence microscopy and immuno-gold electron
microscopy reveal that vacuoles are bounded by SOD1 and mitochondrial outer membrane
markers, but the inner mitochondrial membrane marker is located in focal areas inside the
vacuoles. Small vacuoles contain cytochrome c while large vacuoles are porous and lack
cytochrome c. Vacuoles lack lysosomal signal but contain abundant peroxisomes and SOD1
aggregates.
Conclusion: These findings demonstrate that mutant SOD1, possibly by toxicity associated with
its aggregation, causes mitochondrial degeneration by inducing extension and leakage of the outer
mitochondrial membrane, and expansion of the intermembrane space. This could release the pro-
cell death molecules normally residing in the intermembrane space and initiate motor neuron
degeneration. This Mitochondrial Vacuolation by Intermembrane Space Expansion (MVISE) fits
neither MPT nor autophagic vacuolation mechanisms, and thus, is a previously uncharacterized
mechanism of mitochondrial degeneration in mammalian CNS.
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Background
Amyotrophic lateral sclerosis (ALS) is an age-dependent
neurodegenerative disease that causes progressive
motoneuron degeneration, skeletal muscle atrophy,
paralysis and death [1–3]. Although clinically indistin-
guishable, the majority of cases are sporadic (SALS) and
approximately 10 % are due to inherited causes (familial
ALS or FALS). Of the FALS cases about 20% are due to
mutations in SOD1 [4]. Rodents transgenic for mutant
human SOD1 develop progressive skeletal muscle atro-
phy, paralysis and death similar to human cases [5–8].
The disease causing property of mutant SOD1 is inde-
pendent of the normal SOD1 activity, and thus, mutant
SOD1 kills motor neurons by gaining a toxic property
(reviewed in [9,10]).
Pathological examination of transgenic mice revealed
early changes that are not prominent in human spinal
cord autopsies at the terminal disease stage. These changes
include astrogliosis, fragmentation of Golgi apparatus,
SOD1 aggregation and vacuolar degeneration [7,11–14].
Vacuolar degeneration is most prominent at the onset of
the disease and precedes motoneuron death by two to
three months [15]. Although the high expresser line of
SOD1G93A showed vacuoles derived from both endoplas-
mic reticulum and mitochondria [13], the lower expresser
line of SOD1G93A, which more closely mimics the human
SOD1 levels [16], showed vacuoles that are nearly all
developed from degenerating mitochondria [15,17].
Mitochondrial vacuolation was also reported in another
transgenic line SOD1G37R [7].
The early onset of mitochondrial degeneration suggests
that mutant SOD1 damages mitochondria and this dam-
age plays a causative role in motoneuron degeneration.
Increasing evidence supports this proposal. Mutant SOD1
causes dysfunction and structural damage of mitochon-
dria in cultured neuronal cells [18–20] and at early dis-
ease stages in mutant SOD1 transgenic mice [21,22].
Human ALS also shows mitochondrial damage, dysfunc-
tion and loss [23,24]. The mechanism whereby mutant
SOD1 causes mitochondrial damage has not been deter-
mined, but recent evidence shows that mutant SOD1 is
imported into mitochondria [21,25,26], and this mito-
chondrial localization may cause direct damage to mito-
chondria and induce cell death [27]. Consistent with this
possibility, previous work suggested that mitochondrial
vacuolation was developed from expansion of the inter-
membrane space [17]. However, the possibility that the
vacuoles represent autophagic vacuolation has not been
ruled out, because the source of the vacuolar membrane
was not known.
In the current work we sought to determine whether the
vacuoles are developed from autophagy, MPT or another
mechanism. We examined vacuoles using transmission
electron microscopy (TEM), immunogold electron micro-
scopy and immunoflouresence microscopy. We present
new evidence that, together with the published literature
[17], unequivocally demonstrates that vacuoles are devel-
oped by expansion of mitochondrial intermembrane
space and extension of the outer membrane. This is nei-
ther autophagy nor MPT, but a new mitochondrial degen-
eration mechanism in the CNS.
Results
Patterns of mitochondrial abnormalities revealed by
transmission electron microscopy (TEM) suggest a model
of vacuole formation by extension of mitochondrial outer
membrane and expansion of the intermembrane space
(Fig. 1). Vacuoles might be initiated at focal weakening of
inner and outer mitochondrial membrane contact, result-
ing in small protrusions from the outer membrane (Fig.
1A, arrow). This protrusion might then expand (Fig.
1B,1C, arrows), leading to further detachment of the outer
membrane from the inner membrane (Fig. 1D,1E,
unfilled arrowheads). Eventually the mature vacuoles
form (Fig. 1F,1G,1H,1I), which contain inner membrane
remnants (Fig. 1F,1G,1I, large arrows) and vesicular struc-
tures (Fig. 1H,1I, unfilled arrows). Often noticeable is the
discontinuity in the vacuolar membrane in large vacuoles
(Fig. 1D,1I, small arrows), suggesting that as the vacuoles
expand the vacuolar membrane becomes porous.
To test this model, we immunologically located the inner
and outer membrane components in the vacuoles. We
took advantage of a previous observation that SOD1
marks the boundary of vacuoles [17,28] and doubly
stained spinal cord sections with antibodies against SOD1
and cytochrome c oxidase subunit 1 (CO1), an inner
mitochondrial membrane marker. CO1 and the inner
membrane structure are located focally within the bound-
ary of vacuoles (Fig. 2A,2B,2C,2D). Intense SOD1 signal
is located both at the boundary of the vacuoles and inside
(Fig. 2A,2B,2C,2D), most of which appear to be associ-
ated with membranes (Fig. 2C,2D).
Next, we doubly stained spinal cord sections with anti-
bodies against SOD1 and two protein subunits of TOM
(translocator of outer membrane), TOM20 and TOM40.
Both are outer mitochondrial membrane proteins [29].
Similar to Figure 2, SOD1 signal marked the boundary of
a barrel-shaped vacuole (Fig. 3A,3D). In contrast to the
location of the CO1 signal (Fig. 2), TOM20/40 signals are
at the boundary of the vacuole (Fig. 3B,3E), partially over-
lapping with the SOD1 signal (Fig. 3C,3F, small arrows).
TOM20/40 signals are patchy, concentrated in certain
areas of the vacuolar boundary (large arrows).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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Patterns of mitochondrial vacuoles Figure 1
Patterns of mitochondrial vacuoles. (A) a small outer membrane bud (arrow); (B-D) enlargement of the buds (arrows) 
and expansion of the intermembrane space; (E) further separation of outer and inner membrane and intermembrane space 
expansion; (F-I) patterns of mature vacuoles. Unfilled arrowheads in D-I mark the vacuolar membrane. Large arrows in F-I indi-
cate remnants of inner membrane. Small arrows in D and I indicate broken areas of vacuolar membrane. Small unfilled arrows 
in H and I point to vesicular membranous elements within the vacuoles. Arrowheads in D and F indicate dendritic membranes.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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Because TOM20/40 staining also labeled many normal
mitochondria outside of the vacuoles, the signal near the
vacuole obscured the signal associated with the vacuole.
This left open the possibility that the TOM20/40 signal at
the boundary of the vacuole represents surrounding mito-
chondria, which are compressed by the expanding vacu-
ole. Although this possibility is inconsistent with the
absence of CO1 signal at the vacuolar boundary (Fig. 2),
we further examined this possibility by cutting a middle
section of the vacuole out and visualized it in three
dimensions (Fig. 4). The patches of TOM20/40 signals
(Fig. 4B,4E, arrows) did form a ring around the vacuole,
and this ring overlaps with the inner boundary of the ring
formed by the SOD1 signal (Fig. 4C,4F). This indicates
that mitochondrial outer membrane forms the boundary
of vacuoles and mutant SOD1 may be attached to the out-
side of the vacuolar membrane.
Is cytochrome c, an intermembrane space protein, present
in the expanded intermembrane space? To answer this
question, we doubly stained spinal cord sections with
antibodies against SOD1 and cytochrome c. Inside large
vacuoles cytochrome c signal is absent (Fig.
5A,5B,5C,5D). On the other hand, small vacuoles contain
abundant cytochrome c signal, which nearly completely
overlaps with the SOD1 signal (Fig. 5E,5F,5G,5H,
arrows). As a control, we also examined small vacuoles
doubly stained with SOD1 and CO1 antibodies. CO1 is
still localized focally in these small vacuoles (Fig.
SOD1 is concentrated at the boundary of vacuoles and in  focal areas inside vacuoles, while cytochrome c oxidase subu- nit 1 (CO1) is located only in focal areas inside vacuoles Figure 2
SOD1 is concentrated at the boundary of vacuoles 
and in focal areas inside vacuoles, while cytochrome 
c oxidase subunit 1 (CO1) is located only in focal 
areas inside vacuoles. (A, B) Spinal cord sections from 
SODG93A mice were doubly stained for SOD1 (red) and CO1 
(green). Vacuoles are photographed using a confocal micro-
scope and viewed by 3-d reconstruction. The right panels 
show the superimposition of the red and green signals. The 
two right-most panels are viewed from a 30° angel. White 
circles are added to the top and bottom to aid visualization 
of 3-d structure. Arrows point to small vesicular structure 
inside vacuoles. Arrowheads point to SOD1 aggregates.(C, 
D) Spinal cord sections from SODG93A mice were doubly 
stained for SOD1 (small particles) and CO1 (large particles). 
D is a high magnification view of the mitochondrial matrix 
remnants pointed by the arrowhead in C. The arrow points 
to a vesicular structure inside the vacuole. The arrowhead 
points to the inner membrane remnants within this vacuole.
Mitochondrial outer membrane markers TOM20 and  TOM40 are localized in the vacuolar wall Figure 3
Mitochondrial outer membrane markers TOM20 and 
TOM40 are localized in the vacuolar wall. Spinal cord 
sections were doubly stained with anti-SOD1 (red) and a 
mixture of anti-TOM40 and anti-TOM20 antibodies (green), 
photographed using a confocal microscope, and visualized by 
3-D reconstruction. This vacuole is barrel-shaped. The front 
and the back openings of the vacuole are marked by two line 
circles. D-F are the same vacuole as A-C but rotated down-
wards 30 degrees. Staining using either TOM40 or TOM20 
alone yielded the same staining pattern except that the sig-
nals were somewhat weaker than using both antibodies 
together. Arrowheads in A point to SOD1 aggregates, large 
arrows show patches of TOM and small arrows point to 
where TOM overlaps with SOD1.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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5I,5J,5K,5L, arrows) and only partially overlaps with
SOD1 signal. Together, these observations suggest that
cytochrome c is present in the intermembrane space of the
early, small vacuoles and either being diluted to below the
detection levels in large, intact vacuoles, or leaked out in
the late, large vacuoles because of porous nature of the
large vacuoles (Figs. 1, 2 and 5).
In normal mitochondria the outer membrane wraps
closely around the inner membrane and is not folded like
the inner membrane. Therefore, for the outer membrane
to extend, additional membrane would be needed.
Because, in addition to mitochondria, peroxisomes are
also involved in phospholipid synthesis and metabolism
(see Discussion), we examined whether peroxisomes
might participate in vacuole formation. Vacuoles contain
many catalase-positive granules, the vast majority of
which are positioned closely against the inner vacuolar
wall (Fig. 6B,6C,6D,6F,6G,6H, filled arrows). A small
minority of these granules are attached to the outside of
the vacuolar wall (Fig. 6B,6C,6D,6F,6G,6H, unfilled
arrows). Similarly, numerous PMP70-positive granules
are observed close to the inner wall of the vacuole (Fig.
6J,6K,6L, filled arrows) and a small number of these gran-
ules are attached to the outside (Fig. 6J,6K,6L, unfilled
arrows). Furthermore, catalase signal is present together
with CO1 signal in the same vacuoles (Fig. 7). Finally, cat-
alase signal is also detected in both small and large,
SOD1-positive vacuoles at early disease stages (Fig. 8).
These results suggest that peroxisomes actively participate
in the formation of mitochondrial vacuoles at the early
stages.
Because lysosomes participate in autophagy [30], we
examined whether lysosomes participate in vacuole for-
mation. We doubly stained spinal cord sections with anti-
bodies against SOD1 and cathepsin D, a lysosomal
protease. Vacuoles do not contain high levels of cathepsin
D signal (Fig. 9). For example, the vacuole in figure 9B
contains no more cathepsin D signal than a normal motor
neuron cell body in figure 9F. Noticeably, no cathepsin D
signal is associated with small vacuoles (Fig. 9E,9F,9G,9H,
arrows). These results indicate that lysosomes do not
actively participate in vacuole formation.
The absence of matrix expansion and the involvement of
peroxisomes but not lysosomes together indicate that
mutant SOD1-induced mitochondrial vacuolation is nei-
ther MPT nor autophagy. Because mutant SOD1 is prone
to unfold [31–34] and form aggregates [11,14,35,36], it
has been proposed that abnormal SOD1 aggregation gen-
erates toxicity [10]. To determine whether SOD1 aggre-
gates are involved in mitochondrial vacuolation, we
examined whether vacuoles contain SOD1 aggregates by
immunofluorescence and immuno EM. SOD1 aggregates
are in the majority of vacuoles (Fig. 10; also see figures 2,
3, 5, 6 and 9, arrowheads). In all cases, the aggregates were
found to be on or near the boundary of the vacuoles (Fig.
10, arrowheads). Some SOD1 aggregates overlap with
CO1 signal while others do not (see Fig. 2A and 2B). In
small vacuoles, SOD1 aggregates overlap with
cytochrome c signal (see Fig. 5E,5F,5G). These results sug-
gest a role of mutant SOD1 aggregation in Mitochondrial
Vacuolation by Intermembrane  Space  Expansion
(MVISE).
Discussion
Our EM observations (Fig. 1) suggest that mutant
SOD1G93A causes MVISE in vivo. These observations agree
with an earlier suggestion that vacuoles in the SOD1G93A
mouse model of ALS are derived from the expansion of
mitochondrial intermembrane space [17]. Our subse-
quent experiments confirm this model. First, the inner
mitochondrial membrane does not constitute the vacuole
boundary and is contained within the vacuoles (Fig. 2).
Second, the outer mitochondrial membrane composes a
large part of the vacuolar membrane (Figs. 3, 4). Third,
cytochrome c colocalizes with SOD1 in small vacuoles.
Both molecules are known intermembrane space
Mitochondrial outer membrane markers TOM40 and  TOM20 are localized in the vacuolar wall, inside the SOD1  signal at the vacuolar boundary Figure 4
Mitochondrial outer membrane markers TOM40 and 
TOM20 are localized in the vacuolar wall, inside the 
SOD1 signal at the vacuolar boundary. The panels are 
the mid section of the vacuole shown in Figure 3. D-F are the 
same as A-C but rotated to the right by 45°. Arrows point to 
patches of TOM signal.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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Early vacuoles contain cytochrome c but the late ones do not Figure 5
Early vacuoles contain cytochrome c but the late ones do not. Spinal cord sections from SOD1G93A mice at the pre-
muscle-weakness (PMW) stage were stained with anti-SOD1 (red) and anti-cyt c (green) antibodies (A-H), or anti-SOD1 (red) 
and anti-CO1 (green) antibodies (I-L), and shown as 3-D reconstructed confocal images. C, G and K are superimpositions of 
the red and green signals. D, H and L are the same as C, G and K, respectively, but rotated to the right for 30°. Arrows point 
to small vacuoles and arrowheads point to SOD1 aggregates. Early vacuoles contain cytochrome c (E-H) but the late ones do 
not (A-D). Notice that the inner member marker CO1 does not colocalize with SOD1 (I-L).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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Peroxisomes participate in mitochondrial vacuolation Figure 6
Peroxisomes participate in mitochondrial vacuolation. Spinal cord sections from SOD1G93A mice were stained with 
anti-SOD1 (red) and anti-catalase (green) antibodies (A-H), or anti-SOD1 (red) and anti-PMP70 (green) antibodies (I-L), and 
shown as 3-D reconstructed confocal images. C, G and K are superimpositions of the red and green signals. D and H are the 
same as C and G, respectively, but rotated to the right for 30°. L is the same as K but rotated for 90°. Arrows in B-D and F-H 
point to small, catalase-positive granules that line against the inner wall of vacuoles. Arrows in J-L point to small, PMP70-posi-
tive granules that line against the inner wall of vacuoles. Notice one PMP-70 granule in J and K represents two granules when 
viewed at the 90° in L. Unfilled arrows point to granules that lie against the outer wall of the vacuoles.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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proteins. Although cytochrome c signal is lost in the sub-
sequent vacuolar expansion (Fig. 5), this absence could be
due to a dilution of cytochrome c by the increased vacu-
olar volume [17] and leakage of the outer mitochondrial
membrane. Fourth, catalase- and PMP70-positive gran-
ules are concentrated in the vacuoles (Fig. 6,7,8) but lyso-
somes are not (Fig. 9). This suggests that peroxisomes
actively participate in the vacuole formation but lyso-
somes do not play a significant role. These observations
indicate that neither MPT (expansion of matrix) nor
autophagy (in which lysosomes participate) is responsible
for mutant SOD1-induced mitochondrial vacuolation.
Thus, MVISE represents a previously uncharacterized
mechanism of mitochondrial degeneration in the CNS.
How mutant SOD1 causes MVISE is not known but could
be associated with SOD1 localization. Fridovich and col-
leagues first noticed the presence of SOD1 in the inter-
membrane space in liver mitochondria [37]. Although
this was disputed later [38,39], recent experiments in
yeast and mammalian cells reaffirmed the presence of
both wild type and mutant SOD1 in the intermembrane
space of mitochondria [21,25,26,40]. This finding sug-
gests that mutant SOD1 could directly damage
mitochondria by its toxicity. The increased cell death
induced by direct targeting of mutant SOD1 to mitochon-
dria supports this possibility [27]. Interestingly, low levels
(compared with the levels caused by mutant SOD1) of
mitochondrial vacuolation can also be caused by expres-
sion of high levels of wild type SOD1 [7,13,15,41],
suggesting that the mitochondria-damaging property also
exists in the wild type protein and this property strength-
ens by the mutations.
The toxicity produced by mutant SOD1 that leads to mito-
chondrial damage remains to be identified. One possibil-
ity is that mutant SOD1 catalyzes abnormal redox
reactions, thereby producing toxic reactive oxygen species
(ROS) and damaging cellular structures in its vicinity. Two
such activities have been proposed. The first proposes that
the mutated SOD1 interacts with NO to produce perox-
ynitrite (ONOO-), which damages proteins by modifying
tyrosine to nitrotyrosine residues [42–44]. The second
postulates that the mutant SOD1 possesses an enhanced
peroxidase activity, which causes oxidative modification
of nucleic acids, proteins and lipids [45–47]. Both of these
activities require copper at the active center of SOD1.
However, dramatic reduction of copper in SOD1 by
knocking out the copper chaperon for SOD1 (CCS), or by
mutating the copper chelating residues, did not affect ALS
progression in vivo [36,48]. Therefore, the role of copper-
mediated oxidative damage remains unclear [49,50].
An alternative proposal is that the toxicity stems from the
propensity of the mutated SOD1 to aggregate. SOD1
aggregates have been widely observed in mutant SOD1
transgenic mice and in human ALS caused by SOD1 muta-
tions [11,14,35,36]. In cultured cells, mutant SOD1 forms
high molecular weight aggregates when the cells are
stressed by high mutant protein expression [51], proteo-
some inhibition [52] and serum withdraw [27]. The role
of mutant SOD1 aggregation, however, remains unclear.
One study reports that SOD1 aggregation and cell death
stimulating activity are dissociable in mutant SOD1-trans-
fected PC12 cells [53].
Colocalization of catalase and CO1 in vacuoles Figure 7
Colocalization of catalase and CO1 in vacuoles.Spinal 
cord sections from SOD1G93A mice were stained with anti-
catalase (red) and anti-CO1 (green) antibodies. Lower panels 
show the same vacuoles as in the upper panels except that 
the vacuole is turned 45 degrees.
Peroxisoms are involved in early vacuoles Figure 8
Peroxisoms are involved in early vacuoles. Spinal cord 
sections from a SOD1G93A mouse at early disease stage (pre-
muscle weakness stage; see [15]) were stained with anti-
SOD1 (red) and anti-catalase (green) antibodies.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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All studies conducted on SOD1 aggregation thus far have
been on the large aggregates that might be composed of
long fibrils. The role of small, oligomeric SOD1 aggrega-
tion has not been investigated. Recent studies on neurode-
generative diseases, including Parkinson's, Alzheimer's
and prion diseases, suggest that it is not the long fibrils
that produce toxicity and kill neurons, rather, it is the oli-
gomeric aggregation intermediates that produce toxicity
[54,55]. Interestingly, interactions between biomem-
branes and toxic proteins produce a dual effect of both
promoting oligomeric aggregation of the proteins and
membrane damage [56–59], suggesting that one possible
toxicity of oligomeric aggregates is mediated through
damaging membranes. In this context, our observation
that SOD1 aggregates are associated with vacuolar mem-
brane (Figs. 2, 10) suggests that mutant SOD1 interacts
with mitochondrial membrane and this interaction pro-
motes aggregation. The form of these aggregates is not yet
known but could include both the large aggregates (e.g.
Fig. 10, arrowheads) that bind to thioflavin S [36], and
oligomers, which may be represented by the intense
SOD1 immuno-reactive signals associated with vacuolar
membrane (Fig. 10).
The presence of peroxisomes in mutant SOD1-induced
MVISE is a surprise. How this occurs is unclear.
Nevertheless, the higher concentration of peroxisomes in
and around vacuoles suggests that peroxisomes actively
migrate to or proliferate in the vicinity of abnormal mito-
chondria and participate in the vacuolation process. What
might be the role of peroxisome? The answer is not known
but the normal peroxisome function might provide some
clues. Peroxisomes are indispensable in lipid metabolism
and maintenance of lipid homeostasis. Peroxisomes
shorten chains of very long fatty acids, unsaturated fatty
acids and branched fatty acids by β-oxidation [60,61].
They play critical roles in synthesis of ether phospholipids
and cholesterol [62,63]. Peroxisomal abundance is
Lysosomes do not actively participate in vacuole formation Figure 9
Lysosomes do not actively participate in vacuole formation. Spinal cord sections from SOD1G93A mice were stained 
with anti-SOD1 (red) and anti-cathepsin D (green) antibodies, and visualized by 3-D reconstruction of confocal images. C and 
G are superimpositions of the red and green signals. D and H are the same as C and G, respectively, but rotated 30° to the 
right. Arrows point to small vacuoles that contain SOD1 but not cathepsin D signals. MN marks a motor neuron cell body. 
Arrows point to small vacuoles. The arrowhead points to SOD1 aggregates.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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associated with high membrane demand such as myelina-
tion in the central nervous system [64,65] and peroxisome
diseases result in defective myelination [66]. Because the
outer mitochondrial membrane normally tightly wraps
around mitochondria, the extension of the outer mem-
brane during vacuolation requires new membranes.
Peroxisomes could provide the new membranes by either
synthesis of lipids or fusing themselves with the vacuolar
membrane. Alternatively, peroxisomes might be involved
in membrane breakdown in the mitochondrial degenera-
tion process. Interestingly, accumulation of ceramides
and cholesterol esters has been observed in ALS patients
and mice [67], which could be associated with peroxiso-
mal proliferation.
The mitochondrial vacuolation could in part be the result
of persistent mitochondrial dysfunction and further facil-
itate the downstream motor neuron degeneration events.
Our previous study showed that functional decline of
mitochondria appears in the SOD1G93A mice as early as 60
to 100 days of age [22]. This precedes the peak of mito-
chondrial vacuolation and the onset of the disease by two
to three months [15]. Mitochondrial dysfunction can lead
to energy deficiency and ionic imbalance [68], elevated
ROS and oxidative damage [69], and increased sensitivity
of neurons to excitotoxicity [19,70–72]. These effects
could precipitate MVISE, which trigger cell death
programs by releasing pro-apoptotic proteins resided in
the mitochondrial intermembrane space, such as cyto-
chrome c, AIF, SMAC/DIABLO, endo G and Htra/Omi
[73]. The absence of cytochrome c in the porous large vac-
uoles and the presence of cytochrome c in the small
vacuoles (Fig. 5) are consistent with this possibility.
Because the majority of vacuoles develop in distal small
dendrites [28], the release of these proapoptotic mole-
cules may not cause typical apoptotic changes in cell bod-
ies including chromatin condensation and cytoplasmic
blebbing. Indeed, the typical changes are not observed by
EM (Higgins, Kong and Xu, unpublished observation;
also see [74,75]), but widespread caspase activation is
detected in spinal cords [75–77], suggesting the occur-
rence of a neuritic death program [78].
Our results as well as others' show that mitochondrial vac-
uolation provides an important window for examination
of the mechanism whereby mutant SOD1 causes mito-
chondrial damage and motor neuron degeneration. How-
ever, some mutant SOD1 causes motor neuron
degeneration without mitochondrial vacuolation
[8,11,36]. One difference between the mutants that
induce vacuoles and the ones that do not, is that the
former accumulates at higher levels in the mouse spinal
cord than that latter. It is possible that mitochondrial vac-
uolation represents an accelerated form of mitochondrial
damage caused by high levels of mutant SOD1 accumula-
tion. This does present a challenge to examine and define
mitochondrial damage in low mutant SOD1 expressing
transgenic lines.
Vacuoles contain focal SOD1 aggregates Figure 10
Vacuoles contain focal SOD1 aggregates. Panels A-C are 3-D reconstructed images of a vacuole from SOD1G93A mouse 
spinal cord sections stained with anti-SOD1 antibodies (red). The vacuole is bounded by SOD1 and contains many SOD1 
aggregates (arrowheads). Panel D is an immunogold electron microscopic image from SOD1G93A mouse spinal cord stained 
with an anti-SOD1 antibody (5 nm gold) and an anti-cytochrome oxidase subunit 4 antibody (10 nm gold). The arrowhead indi-
cates a region of SOD1 aggregation.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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Conclusions
Taken together, this study reveals a mitochondrial degen-
eration mechanism in the CNS, mitochondrial vacuola-
tion by intermembrane space expansion or MVISE. The
basic features of MVISE are expansion of mitochondrial
intermembrane space, extension of mitochondrial outer
membrane, collapse and/or disintegration of the matrix
and inner membrane, and involvement of peroxisomes.
These features bare resemblances to mitochondrial degen-
eration in other neurodegenerative conditions, including
Alzheimer's disease [79], prion disease [80], Rett syn-
drome [81], excitotoxic neuronal death [70] and Mn++
superoxide dismutase (SOD2) deletion [82]. Although in
none of these conditions are sufficiently detailed observa-
tions available for a comprehensive comparison, MVISE
could play a role in other neurodegenerative disorders.
Mitochondrial vacuolation may contribute to several non-
apopototic cell death pathways, but its role in a wide spec-
trum of neurodegenerative diseases remains to be defined
[83,84].
Methods
Transgenic mice
The low expression line of transgenic mice expressing
human mutant SOD1G93A  (C57BL/6J-TgN(SOD1-
G93A)1Gurdl) were purchased from Jackson Lab (Bar
Harbor, ME) and bred onto FVB background at University
of Massachusetts Medical School animal facility. Non-
transgenic littermates of SODG93A transgenic mice were
used as wild type controls (WT mice). All transgenic mice
were identified using PCR according to Gurney et al. [85].
Mice were maintained at the University of Massachusetts
Medical School animal facility according to the guidelines
set forth by the Institutional Animal Care and Use Com-
mittee (IACUC).
Immunofluorescence Microscopy
Mice were perfused under anesthesia with fixative (4%
paraformaldehyde, 0.1% glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.5). Sections of lumbar spinal cords
from fixed mice were dissected out and 30 µm sections
were cut using a vibratome. Sections were processed for
antibody staining using the following antibodies: rabbit
[86] and sheep (BioDesign) anti-SOD1 (both recognize
mouse and human SOD1), mouse anti-cytochrome c oxi-
dase subunit CO1 and CO4 (Molecular Probes, OR), rab-
bit anti-TOM20 and TOM40 (Santa Cruz Biotechnology,
CA), mouse anti-cytochrome c (BD PharMingen, San
Diego, CA), sheep anti-catalase (The Binding Site, Bir-
mingham, England), rabbit anti-catalase (Calbiochem,
SanDiego, CA), rabbit anti-PMP70 (ABR, Golden, CO or
Axxora, SanDiego, CA), and rabbit anti-cathepsin D
(DAKO, Carpinteria, CA) according to the protocol
described previously [26,28]. The stained sections were
examined and digitized using a confocal microscope
(Leica TCS-SP). Imaging analysis and three-dimensional
reconstruction were conducted using MetaMorph (Uni-
versal Imaging Corp.).
Transmission electron microscopy (TEM)
Animal fixation, tissue dissection, and microscopic analy-
sis were performed as described previously [15]. In brief,
mice were anesthetized and perfused with a solution of
4% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.6. Tissues were kept in the same
solution for further fixation. The L4 and L5 spinal nerve
roots and lumbar spinal cords (a 2 mm segment centered
at the L5 root entry level) were dissected out and post-
fixed with 2% osmium tetroxide in 100 mM cacodylate
buffer, pH 7.6. After dehydration in graded alcohol, the
tissue blocks were embedded in Epon. Thin sections of
ventral horn were cut from the Epon tissue blocks, stained
with uranyl acetate and lead citrate, and visualized using
a Philips CM10 transmission electron microscope.
Immuno-electron microscopy
Mice were perfused under anesthesia with fixative (4%
paraformaldehyde, 0.1% glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.5). Sections of lumbar spinal cords
from fixed mice were dissected out, dehydrated through
an ethanol series to 100% ethanol and embedded in hard
grade LR White resin (EMS, Fort Washington, PA) by
polymerization overnight at 60 deg. C. Sixty five nm sec-
tions were cut from the embedded tissue using a Reichert-
Jung Ultracut E microtome and collected onto gold grids
(200 mesh) (SPI Inc., Westchester, PA). Sections on grids
were processed for immunogold electron microscopy
according to recommendations by the manufacturer of
the gold-conjugated antibodies (Amersham Pharmacia
Biotech, Piscataway, NJ) with some modification. Sec-
tions were etched in 0.1 N HCl for 5 min., rinsed three
times for five min each in TBS (25 mM Tris, 140 mM
NaCl, 2.7 mM KCl, pH 8.0), placed in blocking buffer for
30 min (0.1% gelatin, 1% normal goat serum, 0.3%
Triton-X-100 in TBS), placed in primary antibody (1:10
diluted in blocking buffer for all antibodies used) for 2
hours at room temperature, rinsed 3 times for 5 min each
in TBS, placed in gold-conjugated secondary antibodies
(10 nm gold anti-mouse and 5 nm gold anti-rabbit) for 1
hour, rinsed 3 times in TBS, fixed in 2% glutaraldehyde,
rinsed 3 times in TBS, rinsed in water, stained with Rey-
nold=s lead citrate followed by aqueous 2% uranyl ace-
tate, dried on filter paper and viewed using a Philips
CM10 transmission electron microscope. The following
antibodies and sera were used, normal rabbit serum (Vec-
tor Laboratories Inc., Burlingame, CA), rabbit polyclonal
anti-SOD1 [86], a second rabbit polyclonal anti-SOD1
(Biodesign, Saco, ME) and a mouse monoclonal antibody
against CO1. All antibodies and serum were used at a 1:10
dilution.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/16
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